Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Developed by researchers in Australia, AOD-9604 was initially investigated as a potential anti-obesity drug due to its ability to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat accumulation)
Women who are pregnant or breastfeeding should not use MOTs-C
The TB-500 component thymosin -4 is prohibited at all times under section S2 of the WADA Prohibited List (peptide hormones, growth factors, related substances and mimetics), which expressly names thymosin--4 and its derivatives
Once-weekly GLP1 in adults with overweight or obesity
In compliance with the recommendations for public health, anyone with a cough, fever, loss of taste/or smell, flu-like symptoms
US$ 25.61
US$ 24.90
US$ 23.40
US$ 29.58
US$ 22.64
US$ 22.17
